Prostate cancer
Results
Phase 2
This trial looked at whether dutasteride can shrink prostate cancer in men whose doctors are closely monitoring their cancer (active surveillance).
Recruitment start: 30 June 2010
Recruitment end: 31 January 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mark Emberton
Clinical Imaging Centre
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
University College London (UCL)
University College London Hospitals NHS Foundation Trust
Last reviewed: 05 Dec 2017
CRUK internal database number: 7317
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
